Effect of pentoxifylline on experimentally induced lipid peroxidation in human spermatozoa

M Gavella1, V Lipovac

  • 1Vuk Vrhovac Institute, University Clinic for Diabetes, Endocrinology and Metabolic Diseases, Medical Faculty University of Zagreb, Croatia.

Insights

Pentoxifylline, previously shown to inhibit superoxide production in human spermatozoa, unexpectedly stimulates lipid peroxidation. This drug may negatively impact sperm quality for in vitro fertilization, warranting further investigation.

Area of Science:

  • Reproductive Biology
  • Biochemistry

Background:

  • Pentoxifylline (PTX) is known to inhibit superoxide anion production in human spermatozoa.
  • The impact of PTX on sperm lipid peroxidation remains largely uncharacterized.

Purpose of the Study:

  • To investigate the effect of millimolar concentrations of pentoxifylline on experimentally induced lipid peroxidation in human spermatozoa.
  • To assess the potential adverse effects of PTX on sperm quality, particularly in the context of in vitro fertilization (IVF).

Main Methods:

  • Spermatozoa were preincubated with varying concentrations of pentoxifylline (1.9, 3.7, and 11.2 mmol/l).
  • Lipid peroxidation was measured using the thiobarbituric acid (TBA) assay to quantify malondialdehyde (MDA) formation.
  • Iron-catalyzed lipid peroxidation potential was assessed in spermatozoa from infertile men.

Main Results:

  • Pentoxifylline significantly stimulated malondialdehyde production in a dose-dependent manner.
  • A notable increase in iron-catalyzed lipid peroxidation was observed in the presence of 11.2 mmol/l pentoxifylline.
  • The stimulatory effect on MDA generation was independent of baseline MDA levels in spermatozoa from infertile men.

Conclusions:

  • Pentoxifylline may exacerbate iron-induced lipid peroxidation in the sperm plasma membrane, leading to increased MDA generation.
  • The pro-oxidant effect of pentoxifylline on sperm could adversely affect sperm suspension quality for IVF.
  • Further research is needed to confirm these findings and their clinical implications for assisted reproductive technologies.